E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers B > Headlines for BioLineRx Ltd. > News item
Published on 8/1/2012 in the Prospect News Convertibles Daily, Prospect News Emerging Markets Daily and Prospect News High Yield Daily.

BioLineRx files $75 million shelf covering stock and debt securities

By Devika Patel

Knoxville, Tenn., Aug. 1 - BioLineRx Ltd. filed a $75 million shelf registration in an F-3 filing with the Securities and Exchange Commission.

The registration covers American Depositary Shares, ordinary shares, debt securities, warrants and units.

The debt may be structured as convertibles.

Proceeds will be used for general corporate purposes.

Based in Jerusalem, Israel, BioLineRx is a specialized drug development company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.